Lundbeck hopes long-term Covid-19 effects will boost Trintellix

In a new study by Canadian researchers, Lundbeck's antidepressant dug Trintellix will be tested as a treatment for the long-term cognitive effects of Covid-19.
Photo: PR / Lundbeck
Photo: PR / Lundbeck
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL PEDERSEN

Canadian scientist Roger McIntyre will spearhead a new clinical trial, including 200 participants, to investigate whether Lundbeck's drug Trintellix, which is normally used in depression treatment, can potentially treat Covid-19 long-term effects, reports Danish business daily Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading